EOSINOPHILIC ASTHMA
Clinical trials for EOSINOPHILIC ASTHMA explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC ASTHMA trials appear
Sign up with your email to follow new studies for EOSINOPHILIC ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill tested to tame severe asthma attacks
Disease control TerminatedThis study tested an oral medication called dexpramipexole for people with severe asthma that is not well-controlled by standard inhalers. Over 1,000 participants took either the drug or a placebo pill for one year to see if it reduced the number of serious asthma flare-ups. The …
Matched conditions: EOSINOPHILIC ASTHMA
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New pill tested to tame severe asthma attacks
Disease control TerminatedThis study tested an oral medication called dexpramipexole for people with severe asthma driven by high levels of a specific white blood cell (eosinophils). Over 650 participants took either the drug or a placebo pill for one year to see if it safely reduced the number of serious…
Matched conditions: EOSINOPHILIC ASTHMA
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Extended safety check for promising severe asthma treatment
Disease control TerminatedThis study aimed to check the long-term safety of an experimental drug called dexpramipexole for adults with severe eosinophilic asthma. It enrolled 509 participants who had already completed one of two earlier Phase 3 trials. The main goal was to monitor for side effects and cha…
Matched conditions: EOSINOPHILIC ASTHMA
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC